T2 Biosystems, Inc. Marketable Securities (Current)
T2 Biosystems, Inc. had Marketable Securities (Current) of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-04-01
- 2023-12-31: Marketable Securities, Current $0.00.
- 2022-12-31: Marketable Securities, Current $0.00.
- 2022-09-30: Marketable Securities, Current $0.00.
- 2022-06-30: Marketable Securities, Current $0.00.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-16 |
| 2022-03-31 | $9.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $10.00M 10-K · filed 2023-03-31 |
| 2021-09-30 | $20.04M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $20.08M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $22.62M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $25.40M 10-K · filed 2022-03-23 |
| 2020-09-30 | $21.99M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.25M 10-Q · filed 2020-08-12 |